Dae-Young Kim, M.D. Ph.D., Joon Ho Moon, M.D. Ph.D., and Young Don Joo, M.D. Ph.D.
Blood Res 2014; 49(2): 80-82Yun Hwa Jung, In Sook Woo, Deok Jae Han, and Chi Wha Han
Blood Res 2014; 49(2): 83Il-Geun Song, and Chan-Jeoung Park
Blood Res 2014; 49(2): 84Megan O. Nakashima, and Heesun J. Rogers
Blood Res 2014; 49(2): 85-94Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim, Junsik Hong, Jinny Park, Jae Hoon Lee, Bo Ram Han, Ho Young Kim, Dae Young Zang, Se Hyung Kim, Seong Kyu Park, Dae Sik Hong, Guk Jin Lee, Jong-Youl Jin, and Gyeonggi/Incheon Branch, The Korean Society of Hematology
Blood Res 2014; 49(2): 95-99
In the high-intensity regimen group, survival of the patients showing complete remission (CR) was significantly longer than that of patients who did not show CR (non-CR) (